WASHINGTON, May 1, 2025 – As the nation recognizes May as Women’s Health Month, GO2 for Lung Cancer (GO2) is proud to celebrate a milestone: the Women and Lung Cancer Research and Preventive Services Act of 2025 (H.R. 2319) has successfully advanced through the House Energy and Commerce Committee and is now heading to the Senate.  

“Women are the heart of our families, workplaces, and communities. When a woman is diagnosed with lung cancer, the impact ripples far and wide,” said GO2 for Lung Cancer President and CEO Laurie Ambrose. “This Women’s Health Month, there’s no better way to honor women than by advancing the critical research needed to address their unique health needs.”  

Despite being the leading cause of cancer-related deaths among women, claiming the lives of more than 60.000 women each year, lung cancer remains underfunded and misunderstood, mainly due to outdated assumptions about the disease. More than 80% of women diagnosed with lung cancer today are either former smokers or have never smoked. Women with no smoking history are twice as likely to be diagnosed as men who have never smoked. 

“This swift reintroduction and advancement of H.R. 2319 is a powerful demonstration of what we can achieve through collective action,” Ambrose said. “It sends a clear message: when we unite our voices, meaningful change becomes not only possible but inevitable.” 

Lung cancer impacts women differently than men, ranging from genetic and biological risk factors to differences in treatment response and survivorship needs. Investing in women’s health is not only necessary but a critical way to improve outcomes for women impacted by lung cancer, their families, and society. 

The bill’s progress marks a critical moment in GO2’s ongoing efforts to raise awareness and advocate for the needs of women impacted by lung cancer. For more than two decades, GO2 has been amplifying the call for action and advancing this women’s health imperative. H.R. 2319 is a direct result of sustained advocacy and growing awareness, with a focus on addressing the disparities in research, treatment, and access to care for women facing lung cancer. 

“This Women’s Health Month, we’re not just raising awareness—we’re demanding action,” Ambrose added. “The advancement of H.R. 2319 is a significant step forward and a powerful affirmation of what we can accomplish even in the most challenging times. Now, we urge the Senate to move with the same urgency—for the health and well-being of women and everyone affected by lung cancer.” 

About GO2 for Lung Cancer 
GO2 for Lung Cancer relentlessly confronts lung cancer on every front, every day, for everyone. Founded by patients and survivors, GO2 is dedicated to increasing survival and quality of life for those at risk, diagnosed, and living with lung cancer. For more information, visit go2.org,  Facebook (@GO2forLungCancer), Instagram, X (formerly Twitter, @go2forlungcancr), and LinkedIn (@go2forlungcancer).